223 related articles for article (PubMed ID: 12383518)
1. Identification, localization and receptor characterization of novel mammalian substance P-like peptides.
Kurtz MM; Wang R; Clements MK; Cascieri MA; Austin CP; Cunningham BR; Chicchi GG; Liu Q
Gene; 2002 Aug; 296(1-2):205-12. PubMed ID: 12383518
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1.
Bellucci F; Carini F; Catalani C; Cucchi P; Lecci A; Meini S; Patacchini R; Quartara L; Ricci R; Tramontana M; Giuliani S; Maggi CA
Br J Pharmacol; 2002 Jan; 135(1):266-74. PubMed ID: 11786503
[TBL] [Abstract][Full Text] [Related]
3. A role for tachykinins in female mouse and rat reproductive function.
Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of hemokinin 1: a novel member of the tachykinin family.
Camarda V; Rizzi A; Calo G; Guerrini R; Salvadori S; Regoli D
Life Sci; 2002 Jun; 71(4):363-70. PubMed ID: 12044836
[TBL] [Abstract][Full Text] [Related]
5. Hemokinins and endokinins.
Page NM
Cell Mol Life Sci; 2004 Jul; 61(13):1652-63. PubMed ID: 15224188
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides.
Page NM
Vascul Pharmacol; 2006 Oct; 45(4):200-8. PubMed ID: 16931167
[TBL] [Abstract][Full Text] [Related]
7. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.
Duffy RA; Hedrick JA; Randolph G; Morgan CA; Cohen-Williams ME; Vassileva G; Lachowicz JE; Laverty M; Maguire M; Shan LS; Gustafson E; Varty GB
Neuropharmacology; 2003 Aug; 45(2):242-50. PubMed ID: 12842130
[TBL] [Abstract][Full Text] [Related]
8. Endomorphins interact with tachykinin receptors.
Kosson P; Bonney I; Carr DB; Lipkowski AW
Peptides; 2005 Sep; 26(9):1667-9. PubMed ID: 16112408
[TBL] [Abstract][Full Text] [Related]
9. Analysis of C-terminally substituted tachykinin-like peptide agonists by means of aequorin-based luminescent assays for human and insect neurokinin receptors.
Torfs H; Detheux M; Oonk HB; Akerman KE; Poels J; Van Loy T; De Loof A; Vassart G; Parmentier M; Vanden Broeck J
Biochem Pharmacol; 2002 May; 63(9):1675-82. PubMed ID: 12007570
[TBL] [Abstract][Full Text] [Related]
10. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
11. Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium.
Stumm R; Culmsee C; Schafer MK; Krieglstein J; Weihe E
J Neurosci; 2001 Feb; 21(3):798-811. PubMed ID: 11157066
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice.
Fu CY; Zhao YL; Dong L; Chen Q; Ni JM; Wang R
Brain Behav Immun; 2008 Aug; 22(6):850-60. PubMed ID: 18262387
[TBL] [Abstract][Full Text] [Related]
15. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
16. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
17. Functional characterisation of hemokinin-1 in mouse uterus.
Patak E; Pennefather JN; Gozali M; Candenas L; Kerr K; Exintaris B; Ziccone S; Potteck H; Chetty N; Page NM; Pinto F
Eur J Pharmacol; 2008 Dec; 601(1-3):148-53. PubMed ID: 18977217
[TBL] [Abstract][Full Text] [Related]
18. Hemokinin-1 and substance P stimulate production of inflammatory cytokines and chemokines in human colonic mucosa via both NK
Dai L; Perera DS; Burcher E; Liu L
Neuropeptides; 2020 Aug; 82():102061. PubMed ID: 32600668
[TBL] [Abstract][Full Text] [Related]
19. Molecular recognition of tachykinin receptor selective agonists: insights from structural studies.
Ganjiwale A; Cowsik SM
Mini Rev Med Chem; 2013 Dec; 13(14):2036-46. PubMed ID: 23937231
[TBL] [Abstract][Full Text] [Related]
20. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis.
Zhang Y; Lu L; Furlonger C; Wu GE; Paige CJ
Nat Immunol; 2000 Nov; 1(5):392-7. PubMed ID: 11062498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
